Management of gynecological cancers in the COVID-19 era: a survey from Turkey

COVID-19 gynecologic oncology survey

Journal

Journal of the Turkish German Gynecological Association
ISSN: 1309-0399
Titre abrégé: J Turk Ger Gynecol Assoc
Pays: Turkey
ID NLM: 101272522

Informations de publication

Date de publication:
04 12 2020
Historique:
entrez: 4 12 2020
pubmed: 5 12 2020
medline: 5 12 2020
Statut: ppublish

Résumé

This study aimed to investigate how gynecologic oncologists modified their patient management during Coronavirus disease-2019 (COVID-19) in Turkey. An online survey was sent to gynecologic oncology specialists and fellows in Turkey. It included management questions about strategies for newly diagnosed or recurrent endometrial, cervical, ovarian and vulvar cancer during the pandemic. Participants were asked if treatment of these cancers can be delayed or not and, if yes, the duration of delay. 32.9% of surgeons prescribed oral or intrauterine progesterone for early stage, low-grade endometrial cancer. Conversely, 65.7% and 45.7% of the most surgeons did not change their management for early stage high-grade and advanced stage endometrial cancers respectively, as they perform surgery. 58% and 67.1% of the surgeons continued to prefer standard surgical treatment for microinvasive and early stage cervical cancers, respectively. Radiotherapy was preferred administered with hypofractionated doses for locally advanced cervical cancer (57.1%). While 67.1% of surgeons operated early stage ovarian cancer patients, 50% administered neoadjuvant chemotherapy (NACT) to all advanced stage ovarian cancers and 50% administered more cycles of NACT in preference to interval debulking surgery. 93.7% of the surgeons responded that treatment should not be delayed beyond eight weeks. Most Turkish gynecologic oncologists modified their management of gynecologic cancers due to the COVID-19 pandemic. While chemotherapy was preferred for ovarian cancer, postponement of the surgery, with or without non-surgical options, was considered for early stage, low-grade endometrial cancer. Treatment of gynecologic cancers should be decided on a case by case basis, taking into account local COVID-19 infection rates and availability of health facilities. Prognosis is also an important consideration if delay is contemplated. Standard treatment and normal time-frames should be used if possible. If not, a postponement for a maximum of eight weeks or referral to another center were acceptable alternatives.

Identifiants

pubmed: 33274616
doi: 10.4274/jtgga.galenos.2020.2020.0071
pmc: PMC7726458
doi:

Types de publication

Journal Article

Langues

eng

Pagination

265-271

Références

Cochrane Database Syst Rev. 2019 Oct 31;2019(10):
pubmed: 31684686
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Hum Reprod. 2007 Jul;22(7):1953-8
pubmed: 17449880
J Med Virol. 1991 Jan;33(1):47-50
pubmed: 1901908
Fertil Steril. 2009 Dec;92(6):2122-4
pubmed: 19591991
Facts Views Vis Obgyn. 2020 Apr 1;12(1):3-7
pubmed: 32259155
Mymensingh Med J. 2011 Jul;20(3):507-12
pubmed: 21804521
Int J Gynecol Cancer. 2020 May;30(5):561-563
pubmed: 32221023
J Gynecol Obstet Hum Reprod. 2020 Jun;49(6):101729
pubmed: 32247066
J Minim Invasive Gynecol. 2020 May - Jun;27(4):789-791
pubmed: 32247882
Gynecol Oncol. 2010 Oct;119(1):22-5
pubmed: 20591472
Menopause. 2020 Jul;27(7):771-775
pubmed: 32217887
ESMO Open. 2020 Mar;5(2):
pubmed: 32229501
Int J Gynaecol Obstet. 2020 Jun;149(3):382-383
pubmed: 32275775

Auteurs

Duygu Altın (D)

Clinic of Obstetrics and Gynecology, Ordu University Training and Research Hospital, Ordu, Turkey

İbrahim Yalçın (İ)

Clinic of Obstetrics and Gynecology, Şanlıurfa Training and Research Hospital, Şanlıurfa, Turkey

Ghanim Khatib (G)

Department of Obstetrics and Gynecology, Çukurova University Faculty of Medicine, Adana, Turkey

Mine Dağgez Keleşoğlu (M)

Department of Obstetrics and Gynecology, Erciyes University Faculty of Medicine, Kayseri, Turkey

Sedat Akgöl (S)

Clinic of Obstetrics and Gynecology, University of Health Sciences Turkey, Kanuni Sultan Süleyman Training and Research Hospital, İstanbul, Turkey

Ayşe Büşra Önder (AB)

Clinic of Obstetrics and Gynecology, Bakırköy Dr. Sadi Konuk Training and Research Hospital, İstanbul, Turkey

İlker Kahramanoğlu (İ)

Department of Obstetrics and Gynecology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey

Tevfik Güvenal (T)

Department of Obstetrics and Gynecology, Manisa Celal Bayar University Faculty of Medicine, Manisa, Turkey

Samet Topuz (S)

Department of Obstetrics and Gynecology, İstanbul University İstanbul Faculty of Medicine, İstanbul, Turkey

Fuat Demirkıran (F)

Department of Obstetrics and Gynecology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey

Classifications MeSH